#USA #London #financial results #Clarivate #NYSE CLVT

Clarivate Reports Financial Results for Fourth Quarter and Full Year 2024

Clarivate Plc (NYSE: CLVT), a prominent global provider of transformative intelligence, has unveiled its financial results for the fourth quarter and full year ending December 31, 2024. The report indicates a notable shift in the company's revenue streams and highlights its ongoing strategic evolution amid evolving market challenges.

Revenue Overview

In the fourth quarter of 2024, Clarivate saw total revenues reach $663.0 million, down from $683.7 million in the same period of 2023. This represents a 3.0% decrease, driven primarily by divestitures in its Intellectual Property (IP) and Academic Government (AG) product lines in 2024. Although there was a modest improvement in subscription revenues and transactional sales, it was insufficient to offset the overall decline.

For the full year, total revenue stood at $2.56 billion, decreasing from $2.63 billion in 2023. Organic revenues fell by 1.4%, marking a concerning trend for the firm. Subscription revenue has shown slight resilience, increasing by 0.5% to reach $1.63 billion.

Adjusted Financial Metrics

Despite the overall revenue decline, the net loss for the fourth quarter improved to $191.8 million, a significant enhancement compared to a loss of $843.9 million during Q4 2023. Adjusted net income for the quarter was $145.5 million, or $0.21 per diluted share. However, the company reported adjusted EBITDA at $285.3 million, a decrease from $298.2 million reported a year ago.

For the entire year, the net loss was $636.7 million, yet this marks a much-improved scenario relative to the $911.2 million loss reported for 2023. Adjusted net income for the year totaled $525.3 million with an adjusted diluted EPS of $0.73.

Strategic Shifts and Innovations

Matti Shem Tov, the company's CEO, commented on the ongoing transitions within the organization, emphasizing a commitment to health organic growth and modernization of operations. With a dedicated focus on subscription and recurring revenue models, Clarivate has initiated a series of AI-driven product enhancements intended to cater to clients in Academia, Government, and Life Sciences sectors.

Furthermore, the company has undertaken an aggressive capital allocation strategy, including the repurchase of $200 million in ordinary shares and pre-paying $198 million of its term loan debt in 2024.

Forward-Looking Statements

Looking ahead to 2025, Clarivate has projected a challenging road with expectations of flat recurring organic revenue growth. The company has indicated plans to discontinue certain low-margin transactional products, aiming to mitigate losses and stabilize revenues. Clarivate intends to remain proactive in exploring strategic alternatives, encompassing potential divestitures aimed at maximizing shareholder value.

In summary, while Clarivate's 2024 financial results reveal both challenges and improvements in specific areas, the company's ongoing commitment to innovation and strategic restructuring could set the stage for a more resilient performance in the coming years.